Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

Medtronic's adjusted third-quarter profit tops analyst estimates but its surgical-products revenue dips on temporary inventory issue Medtronic PLC's stock fell 7% as one of the worst performers in ...

Medtronic‘s next-gen renal denervation (RDN) catheter and procedure are already in the works to advance the Symplicity Spyral system and procedure that won FDA approval for treating hypertension in ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

5 analysts have expressed a variety of opinions on Medtronic MDT over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

After hours: 7:45:18 pm GMT-5 ...

Diagnosis Hyperthyroidism caused by a mixed pituitary adenoma that secretes prolactin and TSH. Management Trans-sphenoidal resection of the pituitary tumor. After surgery, T 3 suppression test ...

The discectomy is then performed using straight and angled pituitary rongeurs. A thorough search for loose disc fragments is conducted. At the end of the procedure an optional fat graft is placed ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said. Scott Whitaker sent a letter to the HHS calling for staff cuts ...